{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:14:53Z","timestamp":1792451693991,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1378\/chest.12-1594","type":"journal-article","created":{"date-parts":[[2013,1,24]],"date-time":"2013-01-24T16:42:26Z","timestamp":1359045746000},"page":"1699-1708","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":199,"title":["Sildenafil Preserves Exercise Capacity in Patients With Idiopathic Pulmonary Fibrosis and Right-sided Ventricular Dysfunction"],"prefix":"10.1016","volume":"143","author":[{"given":"MeiLan K.","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Bach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Hagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Yow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin R.","family":"Flaherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galen B.","family":"Toews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Anstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando J.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1378\/chest.12-1594_bib1","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000194537","article-title":"Pulmonary hemodynamics in idiopathic pulmonary fibrosis and other interstitial pulmonary diseases","volume":"44","author":"Weitzenblum","year":"1983","journal-title":"Respiration"},{"issue":"3","key":"10.1378\/chest.12-1594_bib2","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1378\/chest.06-3087","article-title":"Pulmonary hypertension in idiopathic pulmonary fibrosis","volume":"132","author":"Patel","year":"2007","journal-title":"Chest"},{"issue":"20","key":"10.1378\/chest.12-1594_bib3","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil citrate therapy for pulmonary arterial hypertension","volume":"353","author":"Gali\u00e8","year":"2005","journal-title":"N Engl J Med"},{"issue":"9337","key":"10.1378\/chest.12-1594_bib4","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(02)11024-5","article-title":"Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial","volume":"360","author":"Ghofrani","year":"2002","journal-title":"Lancet"},{"issue":"3","key":"10.1378\/chest.12-1594_bib5","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1378\/chest.06-2101","article-title":"Sildenafil improves walk distance in idiopathic pulmonary fibrosis","volume":"131","author":"Collard","year":"2007","journal-title":"Chest"},{"issue":"7","key":"10.1378\/chest.12-1594_bib6","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJMoa1002110","article-title":"A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis","volume":"363","author":"Idiopathic Pulmonary Fibrosis Clinical Research Network","year":"2010","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1378\/chest.12-1594_bib7","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1164\/rccm.200210-1130OC","article-title":"Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease","volume":"167","author":"Arcasoy","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1378\/chest.12-1594_bib8","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1378\/chest.129.3.746","article-title":"Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis","volume":"129","author":"Lettieri","year":"2006","journal-title":"Chest"},{"issue":"suppl 6","key":"10.1378\/chest.12-1594_bib9","doi-asserted-by":"crossref","first-page":"616S","DOI":"10.1378\/chest.128.6_suppl.616S","article-title":"The impact of pulmonary hypertension on survival in patients with idiopathic pulmonary fibrosis","volume":"128","author":"Nadrous","year":"2005","journal-title":"Chest"},{"issue":"1","key":"10.1378\/chest.12-1594_bib10","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.jacc.2009.04.017","article-title":"Updated evidence-based treatment algorithm in pulmonary arterial hypertension","volume":"54","author":"Barst","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.12-1594_bib11","first-page":"A5301","article-title":"Presence of right ventricular dysfunction modifies treatment response to sildenafil in the Step-IPF Trial","volume":"183","author":"Han","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.12-1594_bib12","first-page":"3S","article-title":"Presence of right ventricular dysfunction predicts dyspnea and quality of life improvements with sildenafil in IPF","volume":"38","author":"Han","year":"2011","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1378\/chest.12-1594_bib13","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1164\/rccm.200308-1142OC","article-title":"Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension","volume":"170","author":"Leuchte","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1378\/chest.12-1594_bib14","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1440-1843.2010.01909.x","article-title":"Exercise capacity in idiopathic pulmonary fibrosis: the effect of pulmonary hypertension","volume":"16","author":"Boutou","year":"2011","journal-title":"Respirology"},{"issue":"9","key":"10.1378\/chest.12-1594_bib15","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1164\/rccm.201007-1179OC","article-title":"Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference","volume":"183","author":"du Bois","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1378\/chest.12-1594_bib16","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.rmed.2009.09.006","article-title":"The SF-36 and SGRQ: validity and first look at minimum important differences in IPF","volume":"104","author":"Swigris","year":"2010","journal-title":"Respir Med"},{"key":"10.1378\/chest.12-1594_bib17","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1477-7525-5-70","article-title":"Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer","volume":"5","author":"Pickard","year":"2007","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"10.1378\/chest.12-1594_bib18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1164\/rccm.200705-732OC","article-title":"BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis","volume":"177","author":"King","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1378\/chest.12-1594_bib19","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1164\/rccm.201011-1874OC","article-title":"BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis","volume":"184","author":"King","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1378\/chest.12-1594_bib20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000339105","article-title":"Plasma endothelin-1 and vascular endothelial growth factor levels and their relationship to hemodynamics in idiopathic pulmonary fibrosis","volume":"84","author":"Ventetuolo","year":"2012","journal-title":"Respiration"},{"issue":"160","key":"10.1378\/chest.12-1594_bib21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1742-1241.2008.01624.x","article-title":"Pulmonary hypertension in interstitial lung disease","volume":"62","author":"Nathan","year":"2008","journal-title":"Int J Clin Pract Suppl"},{"issue":"4","key":"10.1378\/chest.12-1594_bib22","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1378\/chest.128.4.2393","article-title":"Pulmonary hypertension in patients with idiopathic pulmonary fibrosis","volume":"128","author":"Nadrous","year":"2005","journal-title":"Chest"},{"issue":"25","key":"10.1378\/chest.12-1594_bib23","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1161\/CIRCULATIONAHA.106.685206","article-title":"Pulmonary diseases and the heart","volume":"116","author":"Han","year":"2007","journal-title":"Circulation"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369213604018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369213604018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T06:35:41Z","timestamp":1757918141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369213604018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0012369213604018"],"URL":"https:\/\/doi.org\/10.1378\/chest.12-1594","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717976474.793478052","asserted-by":"object"}]},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sildenafil Preserves Exercise Capacity in Patients With Idiopathic Pulmonary Fibrosis and Right-sided Ventricular Dysfunction","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.12-1594","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}